Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 6
1993 2
1994 2
2003 1
2004 3
2005 3
2006 1
2007 3
2008 3
2011 5
2012 3
2013 8
2014 4
2015 3
2016 3
2017 3
2018 5
2019 2
2020 5
2021 11
2022 5
2023 5
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Nanotechnology-novel therapeutics for CNS disorders.
Srikanth M, Kessler JA. Srikanth M, et al. Nat Rev Neurol. 2012 Apr 24;8(6):307-18. doi: 10.1038/nrneurol.2012.76. Nat Rev Neurol. 2012. PMID: 22526003 Free PMC article. Review.
Cancer stem cells and glioma.
Das S, Srikanth M, Kessler JA. Das S, et al. Among authors: srikanth m. Nat Clin Pract Neurol. 2008 Aug;4(8):427-35. doi: 10.1038/ncpneuro0862. Epub 2008 Jul 15. Nat Clin Pract Neurol. 2008. PMID: 18628751 Review.
Biodegradation of plastic polymers by fungi: a brief review.
Srikanth M, Sandeep TSRS, Sucharitha K, Godi S. Srikanth M, et al. Bioresour Bioprocess. 2022 Apr 8;9(1):42. doi: 10.1186/s40643-022-00532-4. Bioresour Bioprocess. 2022. PMID: 38647755 Free PMC article. Review.
The emerging roles of microRNAs in CNS injuries.
Bhalala OG, Srikanth M, Kessler JA. Bhalala OG, et al. Among authors: srikanth m. Nat Rev Neurol. 2013 Jun;9(6):328-39. doi: 10.1038/nrneurol.2013.67. Epub 2013 Apr 16. Nat Rev Neurol. 2013. PMID: 23588363 Free PMC article. Review.
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Lee I, Kuo HC, Aban IB, Cutter GR, McPherson T, Kaminski HJ, Sussman J, Ströbel P, Oger J, Cea G, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJG, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Minisman G, Sonett JR, Wolfe GI; MGTX study group. Lee I, et al. Neurology. 2020 Aug 11;95(6):e755-e766. doi: 10.1212/WNL.0000000000010031. Epub 2020 Jul 1. Neurology. 2020. PMID: 32611638 Free PMC article. Clinical Trial.
87 results